Advanced Clinical Announces New Vice President of Clinical Operations

Advanced Clinical Announces New Vice President of Clinical Operations
Advanced Clinical today announced an addition to its leadership team: Mark Lanfear has been hired as Vice President, Clinical Operations to lead Advanced Clinical in its expansion of service offerings for 2011.
 
FOR IMMEDIATE RELEASE

PRLog (Press Release) - Dec 01, 2010 - BANNOCKBURN, Ill.-Advanced Clinical, a leader in the Pharmaceutical development industry, today announced an addition to its leadership team: Mark Lanfear has been hired as Vice President, Clinical Operations to lead Advanced Clinical in its expansion of service offerings for 2011.

Mark is respected as a cutting-edge leader in the field of outsourcing in the pharmaceutical industry and using outcomes metrics to influence decision-making. As Vice President of Clinical Operations, Mark is responsible for overseeing all clinical operations. His experience includes managing departments, deliverables, timelines and budgets, and he has directed and executed clinical and data management projects in North America, Eastern Europe, India, and Latin America. Additionally, Mark's therapeutic development experience includes nutritionals, metabolic disease, cardiology, oncology, neurology, virology, gynecology and dermatology.

Over his tenure in the industry, Mark has successfully directed departments within Abbott Laboratories, i3 Statprobe, Pfizer Research and Development, KV Pharmaceuticals, Hoffman-La Roche, and as Vice President of World Wide Strategic Alliances for Kforce Clinical Research. Mark has achieved three FDA approvals during his career. He has been on the speaker faculty of Partnerships Conference and the Clinical Trials Congress, and has contributed to numerous life sciences publications, such as PharmaVOICE, The Monitor, Applied Clinical Trials, and R&D Directives.

"We are thrilled to have someone of Mark's background and experience join our management team.  Mark's commitment to industry innovation, along with his energy, drive and passion for scientific excellence, match perfectly with our goal of Advancing Discoveries through Insight. Advanced Clinical is proud to announce this addition to our team, seeing it as one of many steps to invigorating advancements in process and outcomes in the pharmaceutical industry." said Leo Sheridan, CEO of Advanced Clinical.

Mark earned two Bachelor of Science degrees in biological sciences and health care sciences, both from the University of Michigan. He has participated as an adjunctive professor at the University of Michigan School of Public Health's graduate program in Clinical Research Design and Statistical Analysis, as well as Eastern Michigan University's program in Clinical Research Administration. Mark is a current member of the Drug Information Association, the Association of Clinical Research Professionals, a Contributor to the PharmaVoice periodical and an educational member of the American Diabetes Association.

# # #


About Advanced Clinical: Advanced Clinical provides consulting services, strategic sourcing (CRO), talent management, and technology solutions to the Life Sciences industry. With 15+ years of experience, Advanced Clinical is an established presence in the clinical research field, providing services specifically for Pharmaceutical, Biopharmaceutical, Biotechnology and Medical Device organizations. Advanced utilizes a value-based, "One Team" approach. To learn more, visit http://www.advancedclinical.com.

--- end ---

Suggested Articles

At ASH, Dana-Farber researchers presented promising preclinical data on AMG 701, Amgen's long-lasting BiTE for multiple myeloma, but rivals loom.

The takeover, the first of Paul Hudson’s time as CEO, will give Sanofi an IL-2 drug it thinks can become a foundation of future cancer combinations.

A phase 1/2b test showed Roche's antibody mosunetuzumab can trigger durable responses in a significant minority of hard-to-treat NHL patients.